Benvenga S - Search Results

1

THERAPY OF ENDOCRINE DISEASE: Endocrine-metabolic effects of treatment with multikinase inhibitors.

Fallahi P, Ferrari SM, Elia G, Ragusa F, Paparo SR, Camastra S, Mazzi V, Miccoli M, Benvenga S, Antonelli A. Fallahi P, et al. Among authors: benvenga s. Eur J Endocrinol. 2021 Jan;184(1):R29-R40. doi: 10.1530/EJE-20-0683. Eur J Endocrinol. 2021. PMID: 33112294 Review.

2

Dysregulation of secretion of CXC alpha-chemokine CXCL10 in papillary thyroid cancer: modulation by peroxisome proliferator-activated receptor-gamma agonists.

Antonelli A, Ferrari SM, Fallahi P, Frascerra S, Piaggi S, Gelmini S, Lupi C, Minuto M, Berti P, Benvenga S, Basolo F, Orlando C, Miccoli P. Antonelli A, et al. Among authors: benvenga s. Endocr Relat Cancer. 2009 Dec;16(4):1299-311. doi: 10.1677/ERC-08-0337. Epub 2009 Sep 15. Endocr Relat Cancer. 2009. PMID: 19755523

3

Peroxisome proliferator-activated receptor α agonists modulate Th1 and Th2 chemokine secretion in normal thyrocytes and Graves' disease.

Antonelli A, Ferrari SM, Frascerra S, Corrado A, Pupilli C, Bernini G, Benvenga S, Ferrannini E, Fallahi P. Antonelli A, et al. Among authors: benvenga s. Exp Cell Res. 2011 Jul 1;317(11):1527-33. doi: 10.1016/j.yexcr.2011.04.007. Epub 2011 Apr 30. Exp Cell Res. 2011. PMID: 21565188

4

Circulating chemokine (CXC motif) ligand (CXCL)9 is increased in aggressive chronic autoimmune thyroiditis, in association with CXCL10.

Antonelli A, Ferrari SM, Frascerra S, Galetta F, Franzoni F, Corrado A, Miccoli M, Benvenga S, Paolicchi A, Ferrannini E, Fallahi P. Antonelli A, et al. Among authors: benvenga s. Cytokine. 2011 Aug;55(2):288-93. doi: 10.1016/j.cyto.2011.04.022. Epub 2011 May 20. Cytokine. 2011. PMID: 21601475

5

Antithyroid medications and psychosis.

Vita R, Mazzi V, Antonelli A, Benvenga S. Vita R, et al. Among authors: benvenga s. Expert Opin Drug Saf. 2013 Nov;12(6):865-72. doi: 10.1517/14740338.2013.823397. Epub 2013 Jul 25. Expert Opin Drug Saf. 2013. PMID: 23883069 Review.

6

Increased CXCL9 serum levels in hepatitis C-related mixed cryoglobulinemia, with autoimmune thyroiditis, associated with high levels of CXCL10.

Antonelli A, Fallahi P, Ferrari SM, Colaci M, Giuggioli D, Saraceno G, Benvenga S, Ferri C. Antonelli A, et al. Among authors: benvenga s. J Interferon Cytokine Res. 2013 Dec;33(12):739-45. doi: 10.1089/jir.2012.0091. Epub 2013 Jul 31. J Interferon Cytokine Res. 2013. PMID: 23902475

7

Thyroid dysfunctions induced by tyrosine kinase inhibitors.

Fallahi P, Ferrari SM, Vita R, Di Domenicantonio A, Corrado A, Benvenga S, Antonelli A. Fallahi P, et al. Among authors: benvenga s. Expert Opin Drug Saf. 2014 Jun;13(6):723-33. doi: 10.1517/14740338.2014.913021. Epub 2014 May 12. Expert Opin Drug Saf. 2014. PMID: 24821006 Review.

8

The administration of L-thyroxine as soft gel capsule or liquid solution.

Vita R, Fallahi P, Antonelli A, Benvenga S. Vita R, et al. Among authors: benvenga s. Expert Opin Drug Deliv. 2014 Jul;11(7):1103-11. doi: 10.1517/17425247.2014.918101. Epub 2014 Jun 4. Expert Opin Drug Deliv. 2014. PMID: 24896369 Review.

9

Personalization of targeted therapy in advanced thyroid cancer.

Fallahi P, Ferrari SM, Mazzi V, Vita R, Benvenga S, Antonelli A. Fallahi P, et al. Among authors: benvenga s. Curr Genomics. 2014 Jun;15(3):190-202. doi: 10.2174/1389202915999140404101902. Curr Genomics. 2014. PMID: 24955027 Free PMC article.

10

Peroxisome Proliferator-Activated Receptor- γ in Thyroid Autoimmunity.

Ferrari SM, Fallahi P, Vita R, Antonelli A, Benvenga S. Ferrari SM, et al. Among authors: benvenga s. PPAR Res. 2015;2015:232818. doi: 10.1155/2015/232818. Epub 2015 Feb 1. PPAR Res. 2015. PMID: 25722716 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

372 results

Search Page